Skip to main content

Table 1 Patient demographics and prescription status

From: Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan

Patients information

 Facilities

22

  

 Case

343

  

 Gestational age (weeks), median (range)

31.9 (21.4–41.4)

  

 Postnatal age (days), median (range)

17 (0–267)

  

 Birth weight (g), median (range)

1470 (280–4030)

  

 Bodyweight at dose (g), median (range)

1972 (410–7505)

  

 PMA (weeks), median (range)

36.0 (23.3–71.1)

  

Prescription information

No. (%) of neonates

No. (%) of prescriptions

No. (%) of products

 Total

343

2360

426

  Parenteral

225 (65.6%)

1475 (62.5%)

291 (68.3%)

  Enteral

200 (58.3%)

763 (32.3%)

104 (24.4%)

  Topical

82 (23.9%)

122 (5.2%)

31 (7.3%)